Fenofibrate Capsules (Micronized), 134 mg Capsules, 20-count Unit Dose Blister Packs per carton, ...
FDA Drug Recall #D-0822-2016 — Class III — March 31, 2016
Recall Summary
| Recall Number | D-0822-2016 |
| Classification | Class III — Low risk |
| Date Initiated | March 31, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Amerisource Health Services |
| Location | Columbus, OH |
| Product Type | Drugs |
| Quantity | 228 cartons ( 4,560 capsules) |
Product Description
Fenofibrate Capsules (Micronized), 134 mg Capsules, 20-count Unit Dose Blister Packs per carton, Rx Only, Packaged and Distributed by: American Health Packaging Columbus, Ohio 43217, Carton of 20: NDC 68084-835-32, Individual Dose: NDC 68084-835-33.
Reason for Recall
Labeling: Incorrect or Missing Lot and/or Exp Date
Distribution Pattern
Nationwide
Lot / Code Information
Lot #144332C; Exp. 04/16 Lot #155224; Exp. 05/17
Other Recalls from Amerisource Health Services
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0091-2018 | Class II | Paroxetine Tablets, USP, 30mg, 100 tablets (10 ... | Oct 24, 2017 |
| D-0074-2018 | Class III | Enalapril Maleate Tablets, USP, 5 mg, 100 Table... | Aug 29, 2017 |
| D-0490-2017 | Class II | CycloSPORINE Capsules, USP, 100 mg, 30 count (5... | Feb 8, 2017 |
| D-0520-2017 | Class II | GlipiZIDE Extended-release tablets, 2.5 mg, 30-... | Feb 3, 2017 |
| D-0137-2017 | Class III | Bupropion Hydrochloride Extended-Release Tablet... | Oct 27, 2016 |
Frequently Asked Questions
Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.